323 related articles for article (PubMed ID: 20389299)
1. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.
Xu CF; Reck BH; Xue Z; Huang L; Baker KL; Chen M; Chen EP; Ellens HE; Mooser VE; Cardon LR; Spraggs CF; Pandite L
Br J Cancer; 2010 Apr; 102(9):1371-7. PubMed ID: 20389299
[TBL] [Abstract][Full Text] [Related]
2. Pazopanib-Induced Liver Toxicity in Patients With Metastatic Renal Cell Carcinoma: Effect of UGT1A1 Polymorphism on Pazopanib Dose Reduction, Safety, and Patient Outcomes.
Henriksen JN; Bøttger P; Hermansen CK; Ladefoged SA; Nissen PH; Hamilton-Dutoit S; Fink TL; Donskov F
Clin Genitourin Cancer; 2020 Feb; 18(1):62-68.e2. PubMed ID: 31640912
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.
Takeuchi K; Kobayashi Y; Tamaki S; Ishihara T; Maruo Y; Araki J; Mifuji R; Itani T; Kuroda M; Sato H; Kaito M; Adachi Y
J Gastroenterol Hepatol; 2004 Sep; 19(9):1023-8. PubMed ID: 15304120
[TBL] [Abstract][Full Text] [Related]
4. Combined test for UGT1A1 -3279T-->G and A(TA)nTAA polymorphisms best predicts Gilbert's syndrome in Italian pediatric patients.
Ferraris A; D'Amato G; Nobili V; Torres B; Marcellini M; Dallapiccola B
Genet Test; 2006; 10(2):121-5. PubMed ID: 16792515
[TBL] [Abstract][Full Text] [Related]
5. Effect of UDP-glucuronosyltransferase 1A1 activity on risk for developing Gilbert's syndrome.
Huang MJ; Chen YC; Huang YY; Yang SS; Chen PL; Huang CS
Kaohsiung J Med Sci; 2019 Jul; 35(7):432-439. PubMed ID: 31017737
[TBL] [Abstract][Full Text] [Related]
6. A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia.
Danoff TM; Campbell DA; McCarthy LC; Lewis KF; Repasch MH; Saunders AM; Spurr NK; Purvis IJ; Roses AD; Xu CF
Pharmacogenomics J; 2004; 4(1):49-53. PubMed ID: 14647407
[TBL] [Abstract][Full Text] [Related]
7. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.
Monaghan G; McLellan A; McGeehan A; Li Volti S; Mollica F; Salemi I; Din Z; Cassidy A; Hume R; Burchell B
J Pediatr; 1999 Apr; 134(4):441-6. PubMed ID: 10190918
[TBL] [Abstract][Full Text] [Related]
8. Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants.
Kringen MK; Piehler AP; Grimholt RM; Opdal MS; Haug KB; Urdal P
PLoS One; 2014; 9(2):e90248. PubMed ID: 24587300
[TBL] [Abstract][Full Text] [Related]
9. Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms.
Motzer RJ; Johnson T; Choueiri TK; Deen KC; Xue Z; Pandite LN; Carpenter C; Xu CF
Ann Oncol; 2013 Nov; 24(11):2927-8. PubMed ID: 24107802
[No Abstract] [Full Text] [Related]
10. The combination of new missense mutation with [A(TA)7TAA] dinucleotide repeat in UGT1A1 gene promoter causes Gilbert's syndrome.
D'Angelo R; Rinaldi C; Donato L; Nicocia G; Sidoti A
Ann Clin Lab Sci; 2015; 45(2):202-5. PubMed ID: 25887876
[TBL] [Abstract][Full Text] [Related]
11. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.
Lankisch TO; Behrens G; Ehmer U; Möbius U; Rockstroh J; Wehmeier M; Kalthoff S; Freiberg N; Manns MP; Schmidt RE; Strassburg CP
J Hepatol; 2009 May; 50(5):1010-8. PubMed ID: 19303655
[TBL] [Abstract][Full Text] [Related]
12. TaqMan real time PCR for the Detection of the Gilbert's Syndrome Markers UGT1A1*28; UGT1A1*36 and UGT1A1*37.
Daprà V; Alliaudi C; Galliano I; Dini M; Curcio GL; Calvi C; Archetti M; Gavatorta M; Bergallo M
Mol Biol Rep; 2021 May; 48(5):4953-4959. PubMed ID: 34089128
[TBL] [Abstract][Full Text] [Related]
13. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
Lankisch TO; Moebius U; Wehmeier M; Behrens G; Manns MP; Schmidt RE; Strassburg CP
Hepatology; 2006 Nov; 44(5):1324-32. PubMed ID: 17058217
[TBL] [Abstract][Full Text] [Related]
14. Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma.
Xu CF; Reck BH; Goodman VL; Xue Z; Huang L; Barnes MR; Koshy B; Spraggs CF; Mooser VE; Cardon LR; Pandite LN
J Hepatol; 2011 Jun; 54(6):1237-43. PubMed ID: 21145803
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab.
Lee JS; Wang J; Martin M; Germer S; Kenwright A; Benayed R; Spleiss O; Platt A; Pilson R; Hemmings A; Weinblatt ME; Kaplowitz N; Krasnow J
Pharmacogenet Genomics; 2011 Jul; 21(7):365-74. PubMed ID: 21412181
[TBL] [Abstract][Full Text] [Related]
16. UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib.
Meza-Junco J; Chu QS; Christensen O; Rajagopalan P; Das S; Stefanyschyn R; Sawyer MB
Cancer Chemother Pharmacol; 2009 Dec; 65(1):1-4. PubMed ID: 19672597
[TBL] [Abstract][Full Text] [Related]
17. UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia.
Singer JB; Shou Y; Giles F; Kantarjian HM; Hsu Y; Robeva AS; Rae P; Weitzman A; Meyer JM; Dugan M; Ottmann OG
Leukemia; 2007 Nov; 21(11):2311-5. PubMed ID: 17611564
[TBL] [Abstract][Full Text] [Related]
18. Donor liver uridine diphosphate (UDP)-glucuronosyltransferase-1A1 deficiency causing Gilbert's syndrome in liver transplant recipients.
Te HS; Schiano TD; Das S; Kuan SF; DasGupta K; Conjeevaram HS; Baker AL
Transplantation; 2000 May; 69(9):1882-6. PubMed ID: 10830226
[TBL] [Abstract][Full Text] [Related]
19. Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's Syndrome and glucose-6-phosphate dehydrogenase deficiency.
Kaplan M
J Perinatol; 2001 Dec; 21 Suppl 1():S30-4; discussion S35-9. PubMed ID: 11803413
[TBL] [Abstract][Full Text] [Related]
20. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.
Bosma PJ; Chowdhury JR; Bakker C; Gantla S; de Boer A; Oostra BA; Lindhout D; Tytgat GN; Jansen PL; Oude Elferink RP
N Engl J Med; 1995 Nov; 333(18):1171-5. PubMed ID: 7565971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
